Detalles de la búsqueda
1.
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R).
Z Gastroenterol
; 58(9): 841-846, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32947629
2.
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.
Mol Ther
; 21(9): 1796-805, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23752314
3.
Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C.
Virol J
; 10: 295, 2013 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24073713
4.
Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Gastroenterology
; 141(4): 1422-31, 1431.e1-6, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21763239
5.
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
Hepatology
; 52(6): 1934-47, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21064032
6.
[Chronic Hepatitis C - Therapeutic Options in 2016]. / Aktuelle Therapieoptionen bei chronischer Hepatitis C.
MMW Fortschr Med
; 158 Suppl 1: 54-7, 2016 Jun 09.
Artículo
en Alemán
| MEDLINE | ID: mdl-27259905
7.
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.
PLoS One
; 16(5): e0250833, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33970940
8.
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Gastroenterology
; 137(4): 1280-8.e1-6, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19596013
9.
Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections.
Eur J Gastroenterol Hepatol
; 31(7): 845-852, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30789375
10.
Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Eur J Gastroenterol Hepatol
; 20(8): 778-83, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18617783
11.
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.
Clin Infect Dis
; 49(2): 317-9; author reply 319, 2009 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19538070
12.
Immunology of hepatitis B infection.
Lancet Infect Dis
; 2(1): 43-50, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11892495
13.
Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.
J Exp Med
; 211(10): 2047-59, 2014 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-25225458
14.
Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules.
PLoS One
; 9(8): e105703, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25144233
15.
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
Lancet Infect Dis
; 13(6): 497-506, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23523674
16.
Successful treatment of acute liver failure due to polyarteritis nodosa.
Am J Med
; 113(4): 349-51, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12361830
17.
Recurrence of hepatitis C virus during leucocytopenia and spontaneous clearance after recovery from cytopenia: a case report.
J Med Case Rep
; 1: 169, 2007 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053213
18.
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Vaccine
; 25(26): 4960-6, 2007 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-17466417
19.
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.
PLoS One
; 2(7): e649, 2007 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-17653276
20.
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
Liver Transpl
; 12(10): 1489-95, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16964595